Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

The next frontier – the German outpatient sector

The outpatient sector in Europe, long fragmented into millions of providers, is the new frontier for consolidation. And no market is bigger than Germany where medical offices accounted for €51.5bn of expenditure in 2016 and statutory insurers spent €13.7bn alone on dentistry. Many investors and entrepreneurs have the sector in their sights.

Interview: Klodian Allajbeu, CEO of American Hospital, Albania

American Hospital in Albania has five hospitals, a medical centre and a lab. Set up in 2006, it focussed initially on stemming the tide of private patients going abroad for treatment, not on the difficult task of trying to prize money from a public purse that was being spent almost exclusively on public hospitals. That may soon change, however. Healthcare Nova speaks to CEO Klodian Allajbeau to find out more.

Interview: Anuj Arenja, CEO, QI Spine Clinic

An increasingly sedentary lifestyle in India is creating patients with more back and neck problems. Healthcare Nova speaks to Anuj Arenja, CEO of Indian spinal care chain QI Spine Clinic. He thinks he has a non-surgical answer, and is making £150m plans to more than quadruple his business over the next four years with expansion at home and abroad. 

Intercare deal could be a game-changer

This summer, Mediclinic, the listed South African, Europe and Mid-East hospital giant, quietly bought into Intercare, a South African outpatient, day hospital and sub-acute and rehabilitation hospital network which specialises in value-based healthcare, providing the best outcomes at the lowest costs. Here is why we think the acquisition is a game changer and why this is a business model that could be exported internationally.

Interview: Ben Faircloth, Partner, L.E.K. Consulting

Dentistry is flavour of the month in healthcare services with consolidation taking off right across Europe and private equity placing big bets on the concept of national and even multinational chains. Ben Faircloth, who has advised some of the largest players in Europe, tells us what really makes these businesses work and which models are set to prosper.

“Very profitable” Ober Scharrer heading for a sale?

Rumour has it that German ophthalmology chain Ober Scharrer will be sold in the winter. Of course, its CEO Sibylle Stauch-Eckmann couldn’t possibly comment. Nonetheless, she tells us the group now has 5% of the country’s rapidly consolidating eye-care market and a strong pipeline offering further growth.

Just how close are the tech giants to muscling in on traditional insurers and operators?

Insurers and operators are worried about the threat posed by tech giants like Google, Amazon and Microsoft – and the potential for these capital rich business to muscle out traditional players with big spending and technical know-how. But is this threat really realistic?  Healthcare Nova catches up with Peter Ohnemus, CEO of Swiss health app and health score company dacadoo, to find out more.

Find Us